Skip to content

CGEN

Compugen Ltd.

NASDAQ · ILHealthcareBiotechnology
$2.34-1.27%

Price as of Jul 20, 2026

CGEN capital

Compugen Ltd. capital & dividend

Leverage, liquidity, debt coverage and shareholder-distribution metrics.

Leverage

Debt / equity
0.03x
Net debt / equity
-0.10x
Debt / assets
0.02x
Debt / EBITDA
0.08x
Net debt / EBITDA
-0.27x

Liquidity & coverage

Current ratio
6.23x
Quick ratio
6.23x
Cash ratio
6.12x
Interest coverage
EBITDA / interest
Working capital
$115.2M

Cash & dividend

FCF / debt
0.00x
Cash flow / debt
0.00x
Dividend per share
Dividend yield
Dividend growth 1y

Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.